Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00324870
Status:
COMPLETED
Last Update Posted:
2016-01-13
First Post:
2006-05-10
Brief Title:
Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI